Literature DB >> 24795456

Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells.

Sachiko Hirosue1, Efthymia Vokali1, Vidya R Raghavan1, Marcela Rincon-Restrepo1, Amanda W Lund1, Patricia Corthésy-Henrioud1, Francesca Capotosti1, Cornelia Halin Winter2, Stéphanie Hugues3, Melody A Swartz4.   

Abstract

Until recently, the known roles of lymphatic endothelial cells (LECs) in immune modulation were limited to directing immune cell trafficking and passively transporting peripheral Ags to lymph nodes. Recent studies demonstrated that LECs can directly suppress dendritic cell maturation and present peripheral tissue and tumor Ags for autoreactive T cell deletion. We asked whether LECs play a constitutive role in T cell deletion under homeostatic conditions. In this study, we demonstrate that murine LECs under noninflamed conditions actively scavenge and cross-present foreign exogenous Ags to cognate CD8(+) T cells. This cross-presentation was sensitive to inhibitors of lysosomal acidification and endoplasmic reticulum-golgi transport and was TAP1 dependent. Furthermore, LECs upregulated MHC class I and the PD-1 ligand PD-L1, but not the costimulatory molecules CD40, CD80, or CD86, upon Ag-specific interactions with CD8(+) T cells. Finally, Ag-specific CD8(+) T cells that were activated by LECs underwent proliferation, with early-generation apoptosis and dysfunctionally activated phenotypes that could not be reversed by exogenous IL-2. These findings help to establish LECs as APCs that are capable of scavenging and cross-presenting exogenous Ags, in turn causing dysfunctional activation of CD8(+) T cells under homeostatic conditions. Thus, we suggest that steady-state lymphatic drainage may contribute to peripheral tolerance by delivering self-Ags to lymph node-resident leukocytes, as well as by providing constant exposure of draining peripheral Ags to LECs, which maintain tolerogenic cross-presentation of such Ags.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24795456      PMCID: PMC4025611          DOI: 10.4049/jimmunol.1302492

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain.

Authors:  Gregory Lizée; Genc Basha; Jacqueline Tiong; Jean-Pierre Julien; Meimei Tian; Kaan E Biron; Wilfred A Jefferies
Journal:  Nat Immunol       Date:  2003-10-19       Impact factor: 25.606

2.  ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.

Authors:  Pierre Guermonprez; Loredana Saveanu; Monique Kleijmeer; Jean Davoust; Peter Van Endert; Sebastian Amigorena
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

3.  Phagosomes are competent organelles for antigen cross-presentation.

Authors:  Mathieu Houde; Sylvie Bertholet; Etienne Gagnon; Sylvain Brunet; Guillaume Goyette; Annie Laplante; Michael F Princiotta; Pierre Thibault; David Sacks; Michel Desjardins
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

4.  Dynasore, a cell-permeable inhibitor of dynamin.

Authors:  Eric Macia; Marcelo Ehrlich; Ramiro Massol; Emmanuel Boucrot; Christian Brunner; Tomas Kirchhausen
Journal:  Dev Cell       Date:  2006-06       Impact factor: 12.270

5.  The lymph as a pool of self-antigens.

Authors:  Cristina C Clement; Olaf Rotzschke; Laura Santambrogio
Journal:  Trends Immunol       Date:  2010-12-01       Impact factor: 16.687

6.  Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes.

Authors:  Veronika Lukacs-Kornek; Deepali Malhotra; Anne L Fletcher; Sophie E Acton; Kutlu G Elpek; Prakriti Tayalia; Ai-ris Collier; Shannon J Turley
Journal:  Nat Immunol       Date:  2011-09-18       Impact factor: 25.606

Review 7.  Allergen immunotherapy.

Authors:  Anthony J Frew
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

8.  Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells.

Authors:  Alexander Link; Tobias K Vogt; Stéphanie Favre; Mirjam R Britschgi; Hans Acha-Orbea; Boris Hinz; Jason G Cyster; Sanjiv A Luther
Journal:  Nat Immunol       Date:  2007-09-23       Impact factor: 25.606

Review 9.  CD28 and CTLA-4 coreceptor expression and signal transduction.

Authors:  Christopher E Rudd; Alison Taylor; Helga Schneider
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

10.  Reproducible isolation of lymph node stromal cells reveals site-dependent differences in fibroblastic reticular cells.

Authors:  Anne L Fletcher; Deepali Malhotra; Sophie E Acton; Veronika Lukacs-Kornek; Angelique Bellemare-Pelletier; Mark Curry; Myriam Armant; Shannon J Turley
Journal:  Front Immunol       Date:  2011-09-12       Impact factor: 7.561

View more
  95 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

Review 2.  Antigen archiving by lymph node stroma: A novel function for the lymphatic endothelium.

Authors:  Ross M Kedl; Beth A Tamburini
Journal:  Eur J Immunol       Date:  2015-09-10       Impact factor: 5.532

Review 3.  Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy.

Authors:  Susan N Thomas; Nathan A Rohner; Erin E Edwards
Journal:  Annu Rev Biomed Eng       Date:  2016-02-24       Impact factor: 9.590

Review 4.  Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation's fire?

Authors:  Gabriella R Abouelkheir; Bradley D Upchurch; Joseph M Rutkowski
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-07

5.  Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery.

Authors:  Susan N Thomas; Alex Schudel
Journal:  Curr Opin Chem Eng       Date:  2015-02-01       Impact factor: 5.163

Review 6.  Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.

Authors:  Katharina Maisel; Maria Stella Sasso; Lambert Potin; Melody A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2017-07-08       Impact factor: 15.470

7.  Lymphatic vessels regulate immune microenvironments in human and murine melanoma.

Authors:  Amanda W Lund; Marek Wagner; Manuel Fankhauser; Eli S Steinskog; Maria A Broggi; Stefani Spranger; Thomas F Gajewski; Kari Alitalo; Hans P Eikesdal; Helge Wiig; Melody A Swartz
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

8.  Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression.

Authors:  R J Seager; Cynthia Hajal; Fabian Spill; Roger D Kamm; Muhammad H Zaman
Journal:  Converg Sci Phys Oncol       Date:  2017-07-28

9.  Overcoming immunological barriers in regenerative medicine.

Authors:  Johannes L Zakrzewski; Marcel R M van den Brink; Jeffrey A Hubbell
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

Review 10.  Engineering opportunities in cancer immunotherapy.

Authors:  Laura Jeanbart; Melody A Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.